Major drugmakers are reporting fourth-quarter earnings ranging from modestly better to bleak, but they're all showing dents from the macroeconomic forces that constrain the industry, now and for the foreseeable future....
By LINDA A. JOHNSON, Associated Press: Business
Thu, 01/27/2011 - 3:39pm
Major drugmakers are reporting fourth-quarter earnings ranging from modestly better to bleak, but they're all showing dents from the macroeconomic forces that constrain the industry, now and for the foreseeable future....